Comprehensive medical diagnostics and solutions company, Todos Medical Ltd (OTCMKTS:TOMDF), on August 31, 2022, announced entering into a lease agreement in Cleburn, TX. This will be for an area of 15,200 square-foot botanical supplement manufacturing facility on a 6-acre lot. It will comprise botanical extraction, distillation as well as production capabilities.
Trading Data
On Wednesday, TOMDF stock fell 11.14% to $0.0311 with more than 7.33 million shares, compared to volume of 9.05 million shares. The stock moved within a range of $0.0300 – 0.0352 after opening trade at $0.0350.
Todos Medical Establishes Botanical Supplement Manufacturing Capabilities to Support Tollovid Global Expansion and Initiates CBD-A Production
The facility can produce its 3CL protease inhibitor immune support dietary supplement, Tollovid. Currently, the facility has more than $2,000,000 in botanical manufacturing equipment for producing drugs and supplements. It can manufacture products including tinctures, gummies, drinks, capsules, and syrups.
Gerald E. Commissiong, President & CEO of Todos Medical said that the company has spent the previous two years incubating Tollovid. Commission added that the firm has focused on generating data on the in vitro 3CL protease activity as well as its impact on acute infection clients and Long Haulers.
The CEO also stated that the company had numerous discussions with international distributors believing in the ‘Made in the USA’ quality of the Tollovid brand. As per the company, it can bring the cost of goods sold to a level that it can compete in the supplement market internationally. It will enable the firm full control over manufacturing, and hence scale up. In the last month, the firm has finalized plans and even has brought a team for running a lab.
Key Quote
“We have spent the last two years incubating Tollovid by focusing on generating data on its in vitro 3CL protease activity and its effects on acute infection clients and Long Haulers,” said Gerald E. Commissiong, President & CEO of Todos Medical.
Technical Data
TOMDF stock is trading above the 20-Day and 50-Day Moving averages of $0.0301 and $0.0200 respectively. Moreover, the stock is trading above the 200-Day moving average of $0.0309. The company has a total market capitalization of $37.20 million. The stock is up 110% over the past three months.
